Clinical Trial Update: Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants [Phase 1]

View source ↗

Summary

Phase 1 trial updates efavaleukin alfa in healthy participants across Chinese, Japanese, and Caucasian populations; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Diseases

Drugs mentioned

• Efavaleukin Alfa (efavaleukin alfa)

Snippet

Sponsor: Amgen | Conditions: Inflammatory Diseases | Phase 1 | Status: COMPLETED | Results posted: 2024-03-29